All PlansPrior AuthMedium impact
Magnetic Sphincter Augmentation for the Treatment of Gastroesophageal Reflux Disease (GERD) 7.01.89
Excellus BlueCross BlueShield·NY · Gastroenterology, General Surgery·Digestive System (Gastroenterology)
Effective date
Apr 17, 2025
We identified it
Jul 16, 2026
Summary
Excellus BlueCross BlueShield has established a new coverage policy for Magnetic Sphincter Augmentation (LINX device) for GERD treatment, effective April 17, 2025. The policy is considered medically appropriate when strict clinical criteria are met, including age 18+, documented chronic GERD inadequately controlled by PPIs for 6+ months, physician training requirements, and multiple contraindications must be absent. Billing teams must implement prior authorization requirements and ensure providers meet all documented eligibility criteria before claim submission.
Action Required
By April 17, 2025: Billing team must implement prior authorization workflow for LINX device implantation procedures. Providers must submit: (1) Documentation of chronic symptomatic GERD confirmed by endoscopy, fluoroscopy, or ambulatory pH testing; (2) Evidence of inadequate PPI control for ≥6 months or medical contraindication to PPI; (3) Confirmation of hiatal hernia repair if >3cm; (4) Verification of provider credentials and procedure-specific training; (5) Attestation that patient has none of the listed contraindications (titanium/metal allergies, need for MRI >1.5T, BMI >35, esophageal malignancy, major motility disorders, electrical implants, varices, strictures, scleroderma). Update prior auth request forms to include mandatory fields for each criterion. Flag claims for denial if any of the 9 contraindications are present or documentation is incomplete. Front desk staff must inform referring providers that shared decision-making documentation (including procedure explanation, risks/benefits, condition management, and alternatives) must be completed and retained prior to surgery. Claims submitted without complete prior authorization will be denied.